Alpenglow News & Updates

Alpenglow Biosciences and Incyte Corporation to Present 3D Imaging Research at SID 2025
Elisa Barbieri Elisa Barbieri

Alpenglow Biosciences and Incyte Corporation to Present 3D Imaging Research at SID 2025

Alpenglow Biosciences and Incyte Corporation will present groundbreaking 3D imaging research at SID 2025, showcasing how 3D imaging reveals neuroimmune dynamics in atopic dermatitis treated with ruxolitinib cream. Using Alpenglow’s Aurora 3Di light-sheet microscopy, the study provides unprecedented insights into nerve volume, immune cell distribution, and epidermal remodeling.

Read More